Skip to content

The Disproportionate Intrauterine Growth Intervention Trial At Term (DIGITAT), long-term follow up.

DIGITAT 10-14 years follow up

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24995
Enrollment
1102
Registered
2019-03-12
Start date
2019-04-16
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal growth restriction

Interventions

none in the follow up

Sponsors

ZonMW, UMCG, University of Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: study participants of the original DIGITAT trial

Exclusion criteria

Exclusion criteria: no informed consent

Design outcomes

Primary

MeasureTime frame
neurodevelopmental, behavioral abnormalities in childhood

Secondary

MeasureTime frame
maternal and childhood adverse health outcomes (like hypertensive disease and allergic constitution)

Contacts

Public ContactSanne Gordijn

UMCG

s.j.gordijn@umcg.nl0031647568559

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)